hrt and glp 1 Contraception prescribing in patients on GLP-1 agonist weight-loss drugs Postmenopausal Women Lose More Weight

The obesity treatment market is vast, but affordability remains a material challenge

The evidence balance on compounded GLP-1 safety The National Center for Complementary and Integrative Health (NCCIH), the FDA, and multiple medical societies - including the American Diabetes Association - have published guidance noting that compounded GLP-1 preparations carry additional safety uncertainty compared to FDA-approved finished products

GLP-1RAs Reduce Opioid Overdose and Alcohol Intoxication A large retrospective study of patient health records for Loyola University Chicago shows a 40% drop in opioid overdoses and a 50% drop in alcohol intoxication among people who received GLP-1RAs (typically for diabetes or obesity)

1 This expansion is driven by more than just obesity

The typical weight loss caveat applies results are based on use with diet and exercise

392 e085304